
The International Tennis Integrity Agency announced on Thursday that World No. 2 player Iga Swiatek will face a one-month suspension following a positive test for a banned substance called trimetazidine, which contaminated her melatonin that she was taking regularly. She said it was "unintentional."
Because the positive test was from contamination, the ITIA said Swiatek's result was "at the lowest end of the range for no significant fault or negligence."